Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00961948 · ClinicalTrials.gov registry record
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT00961948: Completed study, sponsored by Mayo Clinic.
NCT00961948 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00961948 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
A prospective, randomized trial to determine indigo carmine dye spraying and narrow band imaging (NBI) of colonic mucosa to detect dysplasia in ulcerative colitis (UC). Confocal laser microscopy may be beneficial in the further assessment of abnormalities identified by these methods.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00961948
The ClinicalTrials.gov registry entry for NCT00961948 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00961948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00961948 about?
NCT00961948 is a clinical study titled "Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis". A prospective, randomized trial to determine indigo carmine dye spraying and narrow band imaging (NBI) of colonic mucosa to detect dysplasia in ulcerative colitis (UC). Confocal laser microscopy may be beneficial in the further assessment of abnormalities identified by these methods.
What is the current status of trial NCT00961948?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2009-06. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT00961948?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.